The mission of the Alzheimer’s Therapeutic Research Institute’s (ATRI) is to rigorously test methods for early detection of and treatments for Alzheimer’s disease (AD). Led by Paul Aisen, MD, ATRI is comprised by a growing set of teams of highly skilled researchers with expertise in biostatistics, psychology, informatics, bench science, molecular neuroimaging, neuroscience and more.